NDC 64980-221
Methylphenidate Hydrochloride 2.5 mg tablet, chewable
On the label: Rising Pharma Holdings, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Tedor Pharma Inc. | Cumberland, RI, United States | Makes it and tests it | Problems found, fixed voluntarilyJun 5, 2025 · 5 inspections |
Recalls
- Feb 7, 2022 · Class II · Rising Pharmaceuticals
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Lots: lot# 25910009, Exp 01/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Methylphenidate: every company that makes it
- Form
- tablet, chewable, oral
- Strength
- 2.5 mg
- Approval
- ANDA ANDA205756
- On the market since
- Dec 18, 2018
- Package NDCs
64980-221-01- Official label
- DailyMed (National Library of Medicine), updated Mar 12, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?